Action Potential Morphology Accurately Predicts Proarrhythmic Risk for Drugs With Potential to Prolong Cardiac Repolarization

Abstract

BACKGROUND: Drug-induced or acquired long QT syndrome occurs as a result of the unintended disruption of cardiac repolarization due to drugs that block cardiac ion channels. These side effects have been responsible for the withdrawal of a range of drugs from market and are a common reason for termination of the development of new drugs in the preclinical stage. Existing approaches to risk prediction are expensive and overly sensitive meaning that recently there have been renewed efforts, largely driven by the comprehensive proarrhythmic assay initiative, to develop more accurate methods for allocation of proarrhythmic risk. METHODS: In this study, we aimed to quantify changes in the morphology of the repolarization phase of the cardiac action potential as an indicator of proarrhythmia, supposing that these shape changes might precede the emergence of ectopic depolarizations that trigger arrhythmia. To do this, we describe a new method of quantifying action potential morphology by measuring the radius of curvature of the repolarization phase both in simulated action potentials, as well as in action potentials measured from induced pluripotent stem cell-derived cardiomyocytes. Features derived from the curvature signal were used as inputs for logistic regressions to predict proarrhythmic risk. RESULTS: Optimal risk classifiers based on morphology were able to correctly classify risk to drugs in the comprehensive proarrhythmic assay initiative panels with very high accuracy (0.9375) and outperformed conventional metrics based on action potential duration at 90% repolarization, triangulation, and charge movement (qNet). CONCLUSIONS: Analysis of action potential morphology in response to proarrhythmic drugs improves prediction of torsadogenic risk. Furthermore, morphology metrics can be measured directly from the action potential, potentially eliminating the burden of undertaking complex screens of potency and drug-binding kinetics against multiple cardiac ion channels. As such, this method has the potential to improve and streamline regulatory assessment of proarrhythmia in preclinical drug development.

Overexpression of multidrug resistance‐associated protein 1 protects against cardiotoxicity by augmenting the doxorubicin efflux from cardiomyocytes

“…Two different hiPSC lines were used in this study: the WTCWT iPSC line obtained from Professor Bruce Conklin (The J. David Gladstone Institutes) and the SCVI 8 iPSC line from Professor Joseph Wu (Stanford Cardiovascular Institute). These lines were chosen as they could be routinely differentiated to >85% cardiomyocyte purity, as shown by staining with cardiac troponin (cTnT) 3–6 . Both lines were maintained on Matrigel (no.…”

Unveiling the Multifaceted Problems Associated with Dysrhythmia

“…Some AEDs are classified as broad-spectrum because they treat a wide range of seizure types. Some medications are known to be ineffective for certain seizure types and, in rare cases, may worsen certain seizure types [ 86 ]. The next major determinant is the drug’s side effect profile.…”

“…Preference is given to drugs with a low risk of drowsiness and cognitive dullness [ 100 ]. When choosing drugs for polytherapy, the mechanism of action is especially important because drugs with similar mechanisms of action may cause synergistic adverse effects [ 86 , 101 ].…”

“…By affecting the inactivation of Na channels, not only are the amplitude and duration of a single action potential affected, but it also reduces the ability of neurons to generate bursts of high-frequency action potentials. For this reason, the disadvantages of antiepileptic drugs are more evident at high discharge rates than at low rates (the so-called use-dependent block) [ 86 , 102 ].…”

“…This may explain the effects of ethosuximide and mesuximide, since these drugs lead to attenuation of T-type Ca 2+ currents in thalamocortical neurons. Depending on the membrane potential of the neuron, due to their interference with calcium channels, they prevent the formation of low-threshold Ca 2+ spikes and thus prevent the formation of shutdowns (absence seizures) [ 86 ]. Benzodiazepines, e.g., clobazam, clonazepam, diazepam, or lorazepam, and barbiturates, e.g., phenobarbital, are allosteric agonists of GABAA receptors and induce hyperpolarization of the cell membrane via these receptors.…”